İlaç Tasarım Kongresi

Welcome to BAU-Drug Design Congress 2014

The main theme of the BAU-Drug Design 2014 will be “Recent Developments in Structure- and Ligand-based Drug Design Methodologies,” which will cover a wide range of critically important sessions. This symposium aims to serve as a platform for interaction among renowned experimental and computational scientists from academia and industry to discuss the latest developments in methodology, application and approaches in the drug design field and to accelerate scientific discovery as well as reflect the key goals of the strategic priorities of the university: Integration, inter-disciplinary research on basic health sciences. The key subjects:

Design and Synthesis of Active Ingredient
Drug-Receptor and Receptor-Receptor Interactions
Applications Related with Original and Generic Drugs
Molecular Modeling
3D Protein Prediction and Modeling
Protein Engineering
Homology Modeling
Molecular Simulations
Molecular Docking
MD Simulations
3D-QSAR
De Novo Drug Design
Micro and Nano Drug Delivery Systems
Molecular Biophysics
Bioinformatics
Patented Drug Design

Bahçeşehir University (BAU) was founded in 1998 as a non-profit foundation university. The university has attracted world-renowned academic staff and created state of the art research and instructional facilities. International students who study at Bahcesehir University gain a memorable study abroad experience in one of the most cosmopolitan and global cities, Istanbul. The university’s mission is to educate youth and mold them into the leaders of tomorrow.

As its ninth faculty, the university has opened a Faculty of Medicine, where research is as much a priority as educating students. One priority is addressing a crucial societal issue in Turkey – the need for fundamental work in the basic health sciences extending to investigations that translate from theory and laboratory to clinical work, to the population and society as a whole. Advancing health involves research ranging from the basic life sciences and disease processes at the molecular and genetic level, to health economics, the social determinants of health, and the ethics of health care, to health policy, promotion and delivery. An integral part of the sustainable research direction is in its ability to maintain strength as a research-intensive university by attracting and retaining researchers who will inspire curiosity and creativity in others and by prioritizing the professional development of the future research leaders. To this end, medical research in biocomputing and rational drug design is one among the cornerstone strategies for the university’s research success.

Dean’s Message

Dear Colleagues,

It is my pleasure and honor to host the “2nd International Bahçeşehir University (BAU) Drug Design Congress” at the Bahcesehir University, School of Medicine, in Istanbul. It will bring together renowned industrial and academic experts to further discuss the recent developments and advances in the drug design field.

The main theme of the BAU-Drug Design 2014 Congress will be “Recent Developments in Structure- and Ligand-based Drug Design Methodologies,” which will cover a wide range of critically important topics such as Molecular Simulations, Molecular Modeling, Docking, De Novo Drug Design, Analysis of Protein/Protein and Drug/Protein Interactions, High Throughput Screening Methods, Pharmacophore Modeling, Structural Bioinformatics, Fragment-based Design, ADME/Tox, Protein Flexibility and Dynamics, and High Performance Computing.

The congress aims to serve as a platform for interaction among leading experimental and computational scientists from academia and industry to discuss the latest developments in methodology, application and approaches in the drug design field and to accelerate scientific discovery as well as reflect the key goals of the strategic priorities of the university: Integration, inter-disciplinary research on basic health sciences.

I look forward to welcoming the participants to this exciting congress in the magical city of Istanbul in April 2014.

Sincerely Yours,

Turker KILIC, MD, Ph.D

Professor of Neurosurgery
Bahcesehir University (BAU)
Faculty of Medicine, Dean
Department of Neurosurgery, Chairman
Istanbul Turkey

Main Subject

The priority subjects in the Congress:

Nanotechnology, chemistry and physics technologies, medical research and biotechnology.

Main Subjects:

Design and Synthesis of Active Ingredient
Drug-Receptor and Receptor-Receptor Interactions
Applications Related with Original and Generic Drugs
Molecular Modeling
3D Protein Prediction and Modeling
Protein Engineering
Homology Modeling
Molecular Simulations
Molecular Docking
MD Simulations
3D-QSAR
De Novo Drug Design
Micro and Nano Drug Delivery Systems
Molecular Biophysics
Bioinformatics
Patented Drug Design

Contact
Scientific Secretariat

Dr. Serdar Durdagi
Bahcesehir University, Faculty of Medicine
E-mail: serdar.durdagi@bahcesehir.edu.tr

Mr. Ozan Konukcu
Bahcesehir University, Faculty of Medicine
E-mail: ozan.konukcu@bahcesehir.edu.tr

http://www.baudrugdesign.com/

CEVAP VER

Please enter your comment!
Please enter your name here